Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 913

1.

Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials.

Cushman TR, Verma V, Khairnar R, Levy J, Simone CB, Mishra MV.

Oncotarget. 2019 Sep 24;10(54):5660-5668. doi: 10.18632/oncotarget.27177. eCollection 2019 Sep 24.

2.

Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

Welsh JW, Heymach JV, Chen D, Verma V, Cushman TR, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Menon H, Nguyen QN, Chang JY, Altan M, Papadimitrakopoulou VA, Simon GR, Raju U, Byers L, Glisson B.

J Thorac Oncol. 2019 Oct 9. pii: S1556-0864(19)33525-7. doi: 10.1016/j.jtho.2019.10.001. [Epub ahead of print]

PMID:
31605794
3.

Genetic variants of DNAH11 and LRFN2 genes and their association with ovarian and breast cancer.

Verma S, Bakshi D, Sharma V, Sharma I, Shah R, Bhat A, Bhat GR, Sharma B, Wakhloo A, Kaul S, Heer V, Bhat A, Abrol D, Verma V, Kumar R.

Int J Gynaecol Obstet. 2019 Oct 12. doi: 10.1002/ijgo.12997. [Epub ahead of print]

PMID:
31605628
4.

Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.

Suhas Solomon S, Quinn TC, Solomon S, McFall AM, Srikrishnan AK, Verma V, Kumar MS, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Thomas DL, Singh Sachdeva K, Lucas GM, Mehta SH.

J Hepatol. 2019 Oct 8. pii: S0168-8278(19)30588-4. doi: 10.1016/j.jhep.2019.09.022. [Epub ahead of print]

PMID:
31604081
5.

Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation.

Hasan S, Abel S, Verma V, Webster P, Arscott WT, Wegner RE, Kirichenko A, Simone CB 2nd.

J Gastrointest Oncol. 2019 Oct;10(5):999-1009. doi: 10.21037/jgo.2019.08.03.

6.

Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma.

Khattab A, Patruni S, Abel S, Hasan S, Ludmir EB, Finley G, Monga D, Wegner RE, Verma V.

J Gastrointest Oncol. 2019 Oct;10(5):918-927. doi: 10.21037/jgo.2019.07.02.

7.

The Phase I/II ACCEPT Trial: Concurrent Cetuximab and Intensity-Modulated Radiotherapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck: Cetuximab and IMRT/Carbon Ions for ACC.

Adeberg S, Akbaba S, Lang K, Held T, Verma V, Nikoghosyan A, Bernhardt D, Münter M, Freier K, Plinkert P, Hauswald H, Herfarth K, Rieken S, Debus J, Jensen AD.

Int J Radiat Oncol Biol Phys. 2019 Oct 3. pii: S0360-3016(19)33860-X. doi: 10.1016/j.ijrobp.2019.09.036. [Epub ahead of print]

PMID:
31586664
8.

Factors predicting for patient refusal of head and neck cancer therapy.

Amini A, Verma V, Li R, Vora N, Kang R, Gernon TJ, Chang S, Karam S, Massarelli E, Maghami EG, Glaser S.

Head Neck. 2019 Oct 4. doi: 10.1002/hed.25966. [Epub ahead of print]

PMID:
31584746
9.

Clinical presentation, national practice patterns, and outcomes of breast adenomyoepithelioma.

Haque W, Verma V, Suzanne Klimberg V, Nangia J, Schwartz M, Brian Butler E, Teh BS.

Breast J. 2019 Oct 2. doi: 10.1111/tbj.13638. [Epub ahead of print]

PMID:
31578797
10.

Perioperative myocardial infarction in a young adult after percutaneous nephrolithotomy.

Kumar R, Prasad RV, Verma VK.

Saudi J Anaesth. 2019 Oct-Dec;13(4):374-376. doi: 10.4103/sja.SJA_813_18.

11.

Total Anomalous Pulmonary Venous Connection.

Bhardwaj R, Sondhi S, Rao S, Verma V.

J Assoc Physicians India. 2019 Aug;67(8):73. No abstract available.

PMID:
31562724
12.

Computer Algorithms in Assessment of Obstructive Sleep Apnoea Syndrome and Its Application in Estimating Prevalence of Sleep Related Disorders in Population.

Katyayan A, Yadav V, Mishra P, Mishra A, Saxena M, Kant S, Garg R, Srivastava A, Verma V.

Indian J Otolaryngol Head Neck Surg. 2019 Sep;71(3):352-359. doi: 10.1007/s12070-019-01607-z. Epub 2019 Feb 8.

PMID:
31559203
13.

Involvement of NLRP3 and NLRC4 Inflammasome in Uropathogenic E. coli Mediated Urinary Tract Infections.

Verma V, Gupta S, Kumar P, Yadav S, Dhanda RS, Gaind R, Arora R, Frimodt-Møller N, Yadav M.

Front Microbiol. 2019 Sep 3;10:2020. doi: 10.3389/fmicb.2019.02020. eCollection 2019.

14.

Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.

Verma V, Shrimali RK, Ahmad S, Dai W, Wang H, Lu S, Nandre R, Gaur P, Lopez J, Sade-Feldman M, Yizhak K, Bjorgaard SL, Flaherty KT, Wargo JA, Boland GM, Sullivan RJ, Getz G, Hammond SA, Tan M, Qi J, Wong P, Merghoub T, Wolchok J, Hacohen N, Janik JE, Mkrtichyan M, Gupta S, Khleif SN.

Nat Immunol. 2019 Sep 24. doi: 10.1038/s41590-019-0519-6. [Epub ahead of print]

PMID:
31551574
15.

Helicobacter pylori helicase loader protein Hp0897 shows unique functions of N- and C-terminal regions.

Kumar A, Saha A, Verma VK, Dhar SK.

Biochem J. 2019 Sep 23. pii: BCJ20190430. doi: 10.1042/BCJ20190430. [Epub ahead of print]

PMID:
31548270
16.

Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.

Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW.

JAMA Oncol. 2019 Sep 17. doi: 10.1001/jamaoncol.2019.2809. [Epub ahead of print]

PMID:
31529018
17.

Complications and adverse events of plaque brachytherapy for ocular melanoma.

Peddada KV, Sangani R, Menon H, Verma V.

J Contemp Brachytherapy. 2019 Aug;11(4):392-397. doi: 10.5114/jcb.2019.87407. Epub 2019 Aug 29.

18.

Establishment of Guidelines for the Control of Glycosylation Reactions and Intermediates by Quantitative Assessment of Reactivity.

Chang CW, Wu CH, Lin MH, Liao PH, Chang CC, Chuang HH, Lin SC, Lam S, Verma VP, Hsu CP, Wang CC.

Angew Chem Int Ed Engl. 2019 Sep 13. doi: 10.1002/anie.201906297. [Epub ahead of print]

PMID:
31518045
19.

Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.

Lin C, Verma V, Lazenby A, Ly QP, Berim LD, Schwarz JK, Madiyalakan M, Nicodemus CF, Hollingsworth MA, Meza JL, Are C, Padussis J, Grem JL.

Am J Clin Oncol. 2019 Oct;42(10):755-760. doi: 10.1097/COC.0000000000000599.

PMID:
31513018
20.

Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer.

Jiang W, Verma V, Haque W, Moreno AC, Koshy M, Butler EB, Teh BS.

Dis Esophagus. 2019 Aug 28. pii: doz073. doi: 10.1093/dote/doz073. [Epub ahead of print]

PMID:
31504359
21.

A case of antepartum pulmonary oedema complicating severe preeclampsia.

Verma V, Waheed AH, Bhatti S, Roon YV.

J Obstet Gynaecol. 2019 Sep 9:1-2. doi: 10.1080/01443615.2019.1645822. [Epub ahead of print] No abstract available.

PMID:
31495237
22.

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy.

Menon H, Chen D, Ramapriyan R, Verma V, Barsoumian HB, Cushman TR, Younes AI, Cortez MA, Erasmus JJ, de Groot P, Carter BW, Hong DS, Glitza IC, Ferrarotto R, Altan M, Diab A, Chun SG, Heymach JV, Tang C, Nguyen QN, Welsh JW.

J Immunother Cancer. 2019 Sep 4;7(1):237. doi: 10.1186/s40425-019-0718-6.

23.

Contemporary perspectives on the use of radiation therapy for locally advanced gallbladder cancer.

Verma V, Crane CH.

Chin Clin Oncol. 2019 Aug;8(4):41. doi: 10.21037/cco.2019.08.12.

24.

Evaluation of SOX2 and podoplanin expression in oral epithelial dysplasia and its correlation with malignant transformation.

Verma V, Chandrashekar C.

J Investig Clin Dent. 2019 Aug 28:e12450. doi: 10.1111/jicd.12450. [Epub ahead of print]

PMID:
31464104
25.

Catalyst- and Solvent-Free Coupling of 2-Methyl Quinazolinones and Isatins: An Environmentally Benign Access of Diastereoselective Schizocommunin Analogues.

Malviya BK, Singh K, Jaiswal PK, Shukla M, Verma VP, Vanangamudi M, Jassal AK, Punjabi PB, Sharma S.

ACS Omega. 2019 Jul 15;4(7):12146-12155. doi: 10.1021/acsomega.9b01514. eCollection 2019 Jul 31.

26.

Empirical Modeling of Electron Transport in Fe/Ti Layered Double Hydroxide Using Exponential, Gaussian and Mixed Gauss-Exponential Distribution.

Roy Chowdhury P, Verma V, Medhi H, Bhattacharyya KG.

ACS Omega. 2019 Jun 18;4(6):10599-10609. doi: 10.1021/acsomega.9b01345. eCollection 2019 Jun 30.

27.

Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy10 enough?

Abel S, Hasan S, Verma V, Weksler B, Colonias A, Horne ZD, Wegner RE.

Lung Cancer. 2019 Sep;135:169-174. doi: 10.1016/j.lungcan.2019.07.014. Epub 2019 Jul 18.

PMID:
31446991
28.

Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies.

Verma V, Ludmir EB, Mesko SM, Brooks ED, Augustyn A, Milano MT, Lin SH, Chang JY, Welsh JW.

Pract Radiat Oncol. 2019 Aug 22. pii: S1879-8500(19)30251-6. doi: 10.1016/j.prro.2019.08.005. [Epub ahead of print]

PMID:
31446147
29.

in silico screening and molecular dynamics simulations study to identify novel potent inhibitors against Mycobacterium tuberculosis DnaG primase.

Hakeem S, Singh I, Sharma P, Verma V, Chandra R.

Acta Trop. 2019 Nov;199:105154. doi: 10.1016/j.actatropica.2019.105154. Epub 2019 Aug 22.

PMID:
31445897
30.

Phenanthridine-Fused Tetracyclic Ring System: Metal-Free Diastereoselective Modular Construction of Highly Constrained Polyheterocycles via Post-Ugi Tandem Modifications.

Singh K, Malviya BK, Jaiswal PK, Verma VP, Chimni SS, Sharma S.

Org Lett. 2019 Aug 15. doi: 10.1021/acs.orglett.9b02340. [Epub ahead of print]

PMID:
31414822
31.

Sericin-coated polyester based air-filter for removal of particulate matter and volatile organic compounds (BTEX) from indoor air.

Verma VK, Subbiah S, Kota SH.

Chemosphere. 2019 Jul 27;237:124462. doi: 10.1016/j.chemosphere.2019.124462. [Epub ahead of print]

PMID:
31394446
32.

A pilot clinical study of the neuromuscular blocker rocuronium to reduce the duration of ventilation after organophosphorus insecticide poisoning.

Dhanarisi J, Shihana F, Harju K, Mohamed F, Verma V, Shahmy S, Vanninen P, Kostiainen O, Gawarammana I, Eddleston M.

Clin Toxicol (Phila). 2019 Jul 31:1-8. doi: 10.1080/15563650.2019.1643467. [Epub ahead of print]

PMID:
31364415
33.

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.

Verma V, Shrimali RK, Ahmad S, Dai W, Wang H, Lu S, Nandre R, Gaur P, Lopez J, Sade-Feldman M, Yizhak K, Bjorgaard SL, Flaherty KT, Wargo JA, Boland GM, Sullivan RJ, Getz G, Hammond SA, Tan M, Qi J, Wong P, Merghoub T, Wolchok J, Hacohen N, Janik JE, Mkrtichyan M, Gupta S, Khleif SN.

Nat Immunol. 2019 Sep;20(9):1231-1243. doi: 10.1038/s41590-019-0441-y. Epub 2019 Jul 29. Erratum in: Nat Immunol. 2019 Sep 24;:.

PMID:
31358999
34.

Classical and Emerging Regulatory Mechanisms of Cytokinesis in Animal Cells.

Verma V, Mogilner A, Maresca TJ.

Biology (Basel). 2019 Jul 26;8(3). pii: E55. doi: 10.3390/biology8030055. Review.

35.

Sex-Based Disparities Among Cancer Clinical Trial Participants.

Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E.

J Natl Cancer Inst. 2019 Jul 27. pii: djz154. doi: 10.1093/jnci/djz154. [Epub ahead of print]

PMID:
31350545
36.

Direct observation of branching MT nucleation in living animal cells.

Verma V, Maresca TJ.

J Cell Biol. 2019 Sep 2;218(9):2829-2840. doi: 10.1083/jcb.201904114. Epub 2019 Jul 24.

PMID:
31340987
37.

Auditory effect of noise exposures among commercial and non-commercial light motor vehicle drivers: A comparative cross-sectional study in Lucknow city.

Manar MK, Verma V, Mohan U, Shukla SP, Singh SK.

J Family Med Prim Care. 2019 Jun;8(6):2023-2028. doi: 10.4103/jfmpc.jfmpc_220_19.

38.

Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer.

Haque W, Verma V, Aghazadeh M, Darcourt J, Butler EB, Teh BS.

Clin Genitourin Cancer. 2019 Oct;17(5):e1069-e1079. doi: 10.1016/j.clgc.2019.06.015. Epub 2019 Jul 2.

PMID:
31331865
39.

Management trends and outcomes of breast angiosarcoma: Is breast conservation feasible?

Hasan S, Metzger A, Wegner R, Verma V, Hilton C, Julian T, Trombetta M.

Breast J. 2019 Jul 12. doi: 10.1111/tbj.13439. [Epub ahead of print]

PMID:
31301088
40.

Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?

Brooks ED, Verma V, Chang JY.

Front Oncol. 2019 Jun 21;9:551. doi: 10.3389/fonc.2019.00551. eCollection 2019. No abstract available.

41.

Biochemical regulation and structural analysis of copper-transporting ATPase in a human hepatoma cell line for Wilson disease.

Agnihotry S, Dhusia K, Srivastav AK, Upadhyay J, Verma V, Shukla PK, Ramteke PW, Gautam B.

J Cell Biochem. 2019 Nov;120(11):18826-18844. doi: 10.1002/jcb.29199. Epub 2019 Jul 9.

PMID:
31286540
42.

Alpha lipoic acid supplementation ameliorates the wrath of simulated tropical heat and humidity stress in male Murrah buffaloes.

Samad HA, Konyak YY, Latheef SK, Kumar A, Khan IA, Verma V, Chouhan VS, Verma MR, Maurya VP, Kumar P, Sarkar M, Singh G.

Int J Biometeorol. 2019 Oct;63(10):1331-1346. doi: 10.1007/s00484-019-01750-w. Epub 2019 Jul 6.

PMID:
31280374
43.

Posterior Nasal Pack After Transpalatal Excision of Juvenile Nasopharyngeal Angiofibroma: Can It be Avoided?

Mishra A, Verma V.

Indian J Otolaryngol Head Neck Surg. 2019 Jun;71(2):278-281. doi: 10.1007/s12070-018-1267-x. Epub 2018 Feb 7.

PMID:
31275844
44.

Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer.

Haque W, Verma V, Hsiao KY, Hatch S, Arentz C, Szeja S, Schwartz M, Niravath P, Bonefas E, Miltenburg D, Brian Butler E, Teh BS.

Breast J. 2019 Jul 4. doi: 10.1111/tbj.13443. [Epub ahead of print]

PMID:
31273872
45.

The Effect of Time to Postoperative Radiation Therapy on Survival in Resected Merkel Cell Carcinoma.

Shinde A, Verma V, Jones BL, Li R, Glaser S, Freeman M, Melstrom L, Kang R, Parvathaneni U, Modi B, Amini A.

Am J Clin Oncol. 2019 Aug;42(8):636-642. doi: 10.1097/COC.0000000000000565.

PMID:
31246585
46.

Neoadjuvant stereotactic body radiation therapy for nonmetastatic pancreatic adenocarcinoma.

Jiang W, Haque W, Verma V, Butler EB, Teh BS.

Acta Oncol. 2019 Sep;58(9):1259-1266. doi: 10.1080/0284186X.2019.1631472. Epub 2019 Jun 25.

PMID:
31237185
47.

Unraveling the factors and mechanism involved in persistence: Host-pathogen interactions in Helicobacter pylori.

Gupta N, Maurya S, Verma H, Verma VK.

J Cell Biochem. 2019 Nov;120(11):18572-18587. doi: 10.1002/jcb.29201. Epub 2019 Jun 25.

PMID:
31237031
48.

Prevention of macrovascular complications in patients with type 2 diabetes mellitus: Review of cardiovascular safety and efficacy of newer diabetes medications.

Kant R, Munir KM, Kaur A, Verma V.

World J Diabetes. 2019 Jun 15;10(6):324-332. doi: 10.4239/wjd.v10.i6.324. Review.

49.

Management of Clinically Lymph Node-Positive Malignant Pleural Mesothelioma.

Verma V, Wegner RE, Adeberg S, Horne ZD, Grover S, Friedberg JS, Simone CB 2nd.

Semin Thorac Cardiovasc Surg. 2019 Jun 19. pii: S1043-0679(19)30177-7. doi: 10.1053/j.semtcvs.2019.06.004. [Epub ahead of print]

PMID:
31226401
50.

Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.

Wang S, Zheng D, Lin C, Lei Y, Verma V, Smith A, Ma R, Enke CA, Zhou S.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819851520. doi: 10.1177/1533033819851520.

Supplemental Content

Support Center